PATENT CLAIM ANALYSIS

Application Number: 16067046
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "225800"]

Abstract:
A method of treating schizophrenia includes parenterally administering to a subject a pharmacological agent that inhibits presynaptic glutamate release, modulates postsynaptic glutamate response, or both.

Claim (Index 7):
The method of  claim 1 , further comprising administering haloperidol, fluphenazine, or aripiprazole.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 94.0
- Lexical Diversity: 1.12
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12793330', '15650912', '14844021', '13810772', '14278573']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7044796234403893
- 35 USC 102 Novelty (BERT): 0.4763701497073597
- Combined Prediction Score: 0.6816686760670863
- Mean Citation Score: 117.438888
- Max Citation Score: 118.14988
- Similarity Product: 77.79476119175911

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test